The High Potency API Contract Manufacturing Market is expected to expand from US$9.1 billion in 2025 to US$20.51 billion by 2034, registering a CAGR of 10.69% from 2026 to 2034. Market growth is being driven by the increasing development of targeted therapies, oncology drugs, and other pharmaceutical products requiring highly potent active pharmaceutical ingredients. Rising...